Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Support Erowid Center with a $45 Donation
And get a blacklight-inked "Erologo" t-shirt!
United Kingdom Schedules of Controlled Drugs

As of Feb 1, 2001.
Archived by erowid.org on Jan 27, 2002.
(see Misuse of Drugs Act 2001 for the complete act)
From http://www.legislation.hmso.gov.uk/
SCHEDULE 1
Regulation 3


CONTROLLED DRUGS SUBJECT TO THE REQUIREMENTS OF REGULATIONS 14, 15, 16, 18, 19, 20, 23, 26 AND 27


     1. The following substances and products, namely -

    (a) Bufotenine

         Cannabinol

         Cannabinol derivatives not being dronabinol or its stereoisomers

         Cannabis and cannabis resin

         Cathinone

         Coca leaf

         Concentrate of poppy-straw

         Eticyclidine

         Etryptamine

         Lysergamide

         Lysergide and other N-alkyl derivatives of lysergamide

         Mescaline

         Methcathinone

         Psilocin

         Raw opium

         Rolicyclidine

         Tenocyclidine

         4-Bromo-2,5-dimethoxy-a-methylphenethylamine

         N,N-Diethyltryptamine

         N,N-Dimethyltryptamine

         2,5-Dimethoxy-alpha,4-dimethylphenethylamine

         N-Hydroxy-tenamphetamine

         4-Methyl-aminorex

    (b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

    (c) the following phenethylamine derivatives, namely - 

    [erowid note: erowid has added our guesses at the PiHKAL names for the following phenethylamines, but this is a first stab at this and we are not 100% positive about all the IDs, so corrections are welcome]

         Allyl(alpha-methyl-3,4-methylenedioxyphenethyl)amine [erowid: aka MDAL, PiHKAL 101]

         2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol [erowid: aka BOHD, PiHKAL 16]

         2-Amino-1-(3,4-dimethoxyphenyl)ethanol [erowid: aka DME, PiHKAL 57]

         Benzyl(alpha-methyl-3,4-methylenedioxyphenethyl)amine [erowid: aka MDBZ, PiHKAL 103]

         4-Bromo-,2,5-trimethoxyphenethylamine [erowid: aka BOB, PiHKAL 13]

         N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine [erowid: aka HOT-17, PiHKAL 89]

         Cyclopropylmethyl(alpha-methyl-3,4-methylenedioxyphenethyl)amine [erowid: aka MDCPM, PiHKAL 104]

         2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine [erowid: aka 2C-G-3, PiHKAL 28 -- If this was what was meant by the British, there is an error on their part. An indane is a 2,3-dihydroindene so there cannot be such a thing as a 2,3-dihydro-indane. The name they probably intended to use was: 2-(4,7-Dimethoxy-2,3-dihydro-1H-inden-5-yl)ethylamine]

         2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine [erowid: aka G-3, PiHKAL 82 - Exactly the same error as in #8. As written, it makes no sense. What was intended, surely, was: 2-(4,7-Dimethoxy-2,3-dihydro-1H-inden-5-yl)-1-methylethylamine]

         2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine [erowid: aka DMCPA, PiHKAL 56]

         2-(1,4-Dimethoxy-2-naphthyl)ethylamine [erowid: aka 2C-G-N, PiHKAL 31]

         2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine [erowid: aka G-N, PiHKAL 86]

         N-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine [erowid: aka HOT-7, PiHKAL 88]

         2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine [erowid: AKA 2C-G-4, PiHKAL 29]

         2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine [erowid: aka G-4, PiHKAL 83]

         alpha, alpha-Dimethyl-3,4-methylenedioxyphenethylamine [erowid: aka MDPH, PiHKAL 116]

         alpha, alpha-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine [erowid: aka MDMP, PiHKAL 113 ]

         Dimethyl(alpha-methyl-3,4-methylenedioxyphenethyl)amine [erowid: aka MDDM, PiHKAL 105]

         N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine [erowid: aka HOT-2, PiHKAL 87]

         4-Iodo-2,5-dimethoxy-a-methylphenethyl(dimethyl)amine [erowid: aka IDNNA , PiHKAL 90]

         2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine [erowid: aka 2C-G-5, PiHKAL 30]

         2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine [erowid: aka G-5, PiHKAL 84]

         2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine [erowid: aka F-22, PiHKAL 80]

         2-Methoxyethyl(alpha-methyl-3,4-methylenedioxyphenethyl)amine [erowid: aka MDMEOET, PiHKAL 112]

         2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine [erowid: aka F-2, PiHKAL 79]

         -Methoxy-3,4-methylenedioxyphenethylamine [erowid: aka BOH, PiHKAL 15]

         1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine [erowid: Ethyl-K, thanks to N]

         1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine [erowid: Methyl-K, thanks to N]

         2-(alpha-Methyl-3,4-methylenedioxyphenethylamino)ethanol [erowid: aka MDHOET, PiHKAL 107]

         alpha-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine [erowid: aka MDPL, PiHKAL 117]

         N-Methyl-N-(alpha-methyl-3,4-methylenedioxyphenethyl)hydroxylamine [erowid: aka FLEA, PiHKAL 81]

         O-Methyl-N-(alpha-methyl-3,4-methylenedioxyphenethyl)hydroxylamine [erowid: aka MDMEO, PiHKAL 111]

         alpha-Methyl-4-(methylthio)phenethylamine [erowid: not found in PiKHAL by me .. analog of 4-MA ; probly not as evil to schedule given 4-MA's toxicity. 2C-T without the 2,5diMeO part. -- Early reports of it were dated 1998, in DEA's Microgram Vol. 31, May, page 150 and June page 174. The initial pharmacological studies were by David Nichols, see European J. Pharm. Vol. 229 pp 31-38 (1992). The British seized some 25,000 tablets (called "Flatliners") which were analyzed as being 4-MTA by the London Toxicology Group.]

         ,3,4,5-Tetramethoxyphenethylamine [erowid: aka BOM, PiHKAL 17]

         ,2,5-Trimethoxy-4-methylphenethylamine [erowid: aka BOD, PiHKAL 14]

    (d) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine, an N-alkylphenethylamine, alpha-methylphenethylamine, an N-alkyl-alpha-methylphenethylamine, alpha-ethylphenethylamine, or an N-alkyl-alpha-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substitutents, whether or not further substituted in the ring by one or more other univalent substituents;

    (e) any compound (not being a compound for the time being specified in Schedule 2) structurally derived from fentanyl by modification in any of the following ways, that is to say -

      (i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;

      (ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;

      (iii) by substitution in the piperidine ring with alkyl or alkenyl groups;

      (iv) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;

      (v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

      (vi) by replacement of the N-propionyl group by another acyl group;

    (f) any compound (not being a compound for the time being specified in Schedule 2) structurally derived from pethidine by modification in any of the following ways, that is to say - 

      (i) by replacement of the l-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

      (ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

      (iii) by substitution in the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

      (iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

      (v) by formation of an N-oxide or of a quaternary base.

     2. Any stereoisomeric form of a substance specified in paragraph 1.

     3. Any ester or ether of a substance specified in paragraph 1 or 2.

     4. Any salt of a substance specified in any of paragraphs 1 to 3.

     5. Any preparation or other product containing a substance or product specified in any of paragraphs 1 to 4, not being a preparation specified in Schedule 5.



SCHEDULE 2
Regulation 3


CONTROLLED DRUGS SUBJECT TO THE REQUIREMENTS OF REGULATIONS 14, 15, 16, 18, 19, 20, 21, 23, 26 AND 27


     1. The following substances and products, namely - 

Acetorphine Levomoramide
Alfentanil Levophenacylmorphan
Allylprodine Levorphanol
Alphacetylmethadol Lofentanil
Alphameprodine Medicinal opium
Alphamethadol Metazocine
Alphaprodine Methadone
Anileridine Methadyl acetate
Benzethidine Methyldesorphine
Benzylmorphine (3-benzylmorphine) Methyldihydromorphine
Betacetylmethadol (6-methyldihydromorphine)
Betameprodine Metopon
Betamethadol Morpheridine
Betaprodine Morphine
Bezitramide Morphine methobromide, morphine N-oxide and
Carfentanil other pentavalent nitrogen morphine derivatives
Clonitazene Myrophine
Cocaine Nicomorphine
Desomorphine Noracymethadol
Dextromoramide Norlevorphanol
Diamorphine Normethadone
Diampromide Normorphine
Diethylthiambutene Norpipanone
Difenoxin Oxycodone
Dihydrocodeinone Oxymorphone
O-carboxymethyloxime Pethidine
Dihydromorphine Phenadoxone
Dimenoxadole Phenampromide
Dimepheptanol Phenazocine
Dimethylthiambutene Phencyclidine
Dioxaphetyl butyrate Phenomorphan
Diphenoxylate Phenoperidine
Dipipanone Piminodine
Dronabinol Piritramide
Drotebanol Proheptazine
Ecgonine, and any derivative of Properidine
ecgonine which is convertible to Racemethorphan
ecgonine or to cocaine Racemoramide
Ethylmethylthiambutene Racemorphan
Etonitazene Sufentanil
Etorphine Thebacon
Etoxeridine Thebaine
Fentanyl Tilidate
Furethidine Trimeperidine
Hydrocodone Zipeprol
Hydromorphinol 4-Cyano-2-dimethylamino-4,4-
Hydromorphone diphenylbutane
Hydroxypethidine 4-Cyano-1-methyl-4-
Isomethadone phenylpiperidine
Ketobemidone 2-Methyl-3-morpholino-1,1-diphenylpropane-
Levomethorphan carboxylic acid
     alpha-Methylphenethylhydroxylamine
     1-Methyl-4-phenylpiperidine-4-carboxylic acid
     4-Phenylpiperidine-4-carboxylic acid ethyl ester

     2. Any stereoisomeric form of a substance specified in paragraph 1 not being dextromethorphan or dextrorphan.

     3. Any ester or ether of a substance specified in paragraph 1 or 2, not being a substance specified in paragraph 6.

     4. Any salt of a substance specified in any of paragraphs 1 to 3.

     5. Any preparation or other product containing a substance or product specified in any of paragraphs 1 to 4, not being a preparation specified in Schedule 5.

     6. The following substances and products, namely - 

Acetyldihydrocodeine Methaqualone
Amphetamine Methylamphetamine
Codeine Methylphenidate
Dextropropoxyphene Nicocodine
Dihydrocodeine Nicodicodine (6-nicotinoyldihydrocodeine)
Ethylmorphine (3-ethylmorphine) Norcodeine
Fenethylline Phenmetrazine
Glutethimide Pholcodine
Lefetamine Propiram
Mecloqualone Quinalbarbitone

     7. Any stereoisomeric form of a substance specified in paragraph 6.

     8. Any salt of a substance specified in paragraph 6 or 7.

     9. Any preparation or other product containing a substance or product specified in any of paragraphs 6 to 8, not being a preparation specified in Schedule 5.



SCHEDULE 3
Regulation 3


CONTROLLED DRUGS SUBJECT TO THE REQUIREMENTS OF REGULATIONS 14, 15 (EXCEPT TEMAZEPAM), 16, 18, 22, 23, 24, 26 AND 27


     1. The following substances, namely - 

    (a)

Benzphetamine Mephentermine
Buprenorphine Meprobamate
Cathine Methylphenobarbitone
Chlorphentermine Methyprylone
Diethylpropion Pentazocine
Ethchlorvynol Phendimetrazine
Ethinamate Phentermine
Flunitrazepam Pipradrol
Mazindol Temazepam

    (b) any 5, 5 disubstituted barbituric acid not being quinalbarbitone.

     2. Any stereoisomeric form of a substance specified in paragraph 1 not being phenylpropanolamine.

     3. Any salt of a substance specified in paragraph 1 or 2.

     4. Any preparation or other product containing a substance specified in any of paragraphs 1 to 3, not being a preparation specified in Schedule 5.



SCHEDULE 4
Regulation 3



PART I

CONTROLLED DRUGS SUBJECT TO THE REQUIREMENTS OF REGULATIONS 22, 23, 26 AND 27

     1. The following substances and products, namely - 

Alprazolam Ketazolam
Aminorex Loprazolam
Bromazepam Lorazepam
Brotizolam Lormetazepam
Camazepam Medazepam
Chlordiazepoxide Mefenorex
Clobazam Mesocarb
Clonazepam Midazolam
Clorazepic acid Nimetazepam
Clotiazepam Nitrazepam
Cloxazolam Nordazepam
Delorazepam Oxazepam
Diazepam Oxazolam
Estazolam Pemoline
Ethyl loflazepate Pinazepam
Fencamfamin Prazepam
Fenproporex Pyrovalerone
Fludiazepam Tetrazepam
Flurazepam Triazolam
Halazepam N-Ethylamphetamine
Haloxazolam  

     2. Any stereoisomeric form of a substance specified in paragraph 1.

     3. Any salt of a substance specified in paragraph 1 or 2.

     4. Any preparation or other product containing a substance or product specified in any of paragraphs 1 to 3, not being a preparation specified in Schedule 5.



PART II

CONTROLLED DRUGS EXCEPTED FROM THE PROHIBITION ON POSSESSION WHEN IN THE FORM OF A MEDICINAL PRODUCT; EXCLUDED FROM THE APPLICATION OF OFFENCES ARISING FROM THE PROHIBITION ON IMPORTATION AND EXPORTATION WHEN IMPORTED OR EXPORTED IN THE FORM OF A MEDICINAL PRODUCT BY ANY PERSON FOR ADMINISTRATION TO HIMSELF; AND SUBJECT TO THE REQUIREMENTS OF REGULATIONS 22, 23, 26 AND 27

     1. The following substances, namely - 

Atamestane Methenolone
Bolandiol Methyltestosterone
Bolasterone Metribolone
Bolazine Mibolerone
Boldenone Nandrolone
Bolenol Norboletone
Bolmantalate Norclostebol
Calusterone Norethandrolone
4-Chloromethandienone Ovandrotone
Clostebol Oxabolone
Drostanolone Oxandrolone
Enestebol Oxymesterone
Epitiostanol Oxymetholone
Ethyloestrenol Prasterone
Fluoxymesterone Propetandrol
Formebolone Quinbolone
Furazabol Roxibolone
Mebolazine Silandrone
Mepitiostane Stanolone
Mesabolone Stanozolol
Mestanolone Stenbolone
Mesterolone Testosterone
Methandienone Thiomesterone
Methandriol Trenbolone

     2. Any compound (not being Trilostane or a compound for the time being specified in paragraph 1 of this Part of this Schedule) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say -

    (a) by further substitution at position 17 by a methyl or ethyl group;

    (b) by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;

    (c) by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

    (d) by fusion of ring A with a heterocyclic system.

     3. Any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in paragraph 1 or described in paragraph 2 of this Part of this Schedule.

     4. The following substances, namely - 

Chorionic Gonadotrophin (HCG)

Clenbuterol

Non-human chorionic gonadotrophin

Somatotropin

Somatrem

Somatropin

     5. Any stereoisomeric form of a substance specified or described in any of paragraphs 1 to 4 of this Part of this Schedule.

     6. Any salt of a substance specified or described in any of paragraphs 1 to 5 of this Part of this Schedule.

     7. Any preparation or other product containing a substance or product specified or described in any of paragraphs 1 to 6 of this Part of this Schedule, not being a preparation specified in Schedule 5.



SCHEDULE 5
Regulation 3


CONTROLLED DRUGS EXCEPTED FROM THE PROHIBITION ON IMPORTATION, EXPORTATION AND POSSESSION AND SUBJECT TO THE REQUIREMENTS OF REGULATIONS 24 AND 26


     1.  - (1) Any preparation of one or more of the substances to which this paragraph applies, not being a preparation designed for administration by injection, when compounded with one or more other active or inert ingredients and containing a total of not more than 100 milligrams of the substance or substances (calculated as base) per dosage unit or with a total concentration of not more than 2.5% (calculated as base) in undivided preparations.

    (2) The substances to which this paragraph applies are acetyldihydrocodeine, codeine, dihydrocodeine, ethylmorphine, nicocodine, nicodicodine (6-nicotinoyldihydrocodeine), norcodeine and pholcodine and their respective salts.

     2. Any preparation of cocaine containing not more than 0.1% of cocaine calculated as cocaine base, being a preparation compounded with one or more other active or inert ingredients in such a way that the cocaine cannot be recovered by readily applicable means or in a yield which would constitute a risk to health.

     3. Any preparation of medicinal opium or of morphine containing (in either case) not more than 0.2% of morphine calculated as anhydrous morphine base, being a preparation compounded with one or more other active or inert ingredients in such a way that the opium or, as the case may be, the morphine cannot be recovered by readily applicable means or in a yield which would constitute a risk to health.

     4. Any preparation of dextropropoxyphene, being a preparation designed for oral administration, containing not more than 135 milligrams of dextropropoxyphene (calculated as base) per dosage unit or with a total concentration of not more than 2.5% (calculated as base) in undivided preparations.

     5. Any preparation of difenoxin containing, per dosage unit, not more than 0.5 milligrams of difenoxin and a quantity of atropine sulphate equivalent to at least 5% of the dose of difenoxin.

     6. Any preparation of diphenoxylate containing, per dosage unit, not more than 2.5 milligrams of diphenoxylate calculated as base, and a quantity of atropine sulphate equivalent to at least 1% of the dose of diphenoxylate.

     7. Any preparation of propiram containing, per dosage unit, not more than 100 milligrams of propiram calculated as base and compounded with at least the same amount (by weight) of methylcellulose.

     8. Any powder of ipecacuanha and opium comprising - 

    10% opium, in powder,

    10% ipecacuanha root, in powder, well mixed with

    80% of any other powdered ingredient containing no controlled drug.

     9. Any mixture containing one or more of the preparations specified in paragraphs 1 to 8, being a mixture of which none of the other ingredients is a controlled drug.



SCHEDULE 6
Regulation 19


SCHEDULE 7
Regulation 28


Crown copyright 2001 Prepared 20 December 2001